Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Oral Tranexamic Acid in Primary Total Joint Arthroplasty
NCT06832878Phase 4Recruiting
- Sponsor
- Mayo Clinic
- Start
- Jun 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in osteoarthritis (OA), sponsored by Mayo Clinic. Started Jun 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06832878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06832878.